Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

General Meeting Statement

30 Oct 2023 07:00

RNS Number : 6221R
Versarien PLC
30 October 2023
 

 

 

30 October 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

General Meeting Statement

 

Versarien plc (AIM: VRS), the advanced materials engineering group, will be holding a General Meeting at 10.00 a.m. today, at which the following statement will be provided:

 

"Versarien's turnaround continues to progress in line with its stated strategy and we are pleased to provide a further update on progress following the Company's most recent corporate update on 2 October 2023.

 

The mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and we have a number of interested parties that we are progressing discussions with. The sale process for AAC Cyroma Limited, a manufacturer of moulded products, is the most advanced. However, the timing of any asset sales and the total quantum of the funds that may be received remains uncertain.

 

Further commercial progress continues to be made in the Company's core areas of leisure and construction. In the leisure area, discussions have been held with a number of potential new customers for the Company's Graphene-Wear? coatings in recent weeks.

 

In construction, in addition to a number of ongoing Cementene? trials, the Company is engaged in the production of additional 3D printed concrete structures and Versarien's participation in the Digital Roads of the Future and Roads Research Alliance programmes is generating further potential opportunities, including the potential use of graphene in asphalt resurfacing.

 

The Company continues to focus on obtaining and executing funded research and development projects. As referenced in the Company's Corporate Update announcement on 2 October 2023, Gnanomat S.L. is undertaking a nine-month project, at an undisclosed value, with CBMM Technology Suisse SA (part of Brazilian mining giant CBMM), to develop novel supercapacitors and 2-DTech Limited has a £44,200 contract, over approximately 14 weeks, with a UK aviation company to assess graphene / thermoset composites. Versarien Graphene Limited was also recently awarded a £48,600 contract by the Office of Product Safety and Standards, part of the UK Department for Business and Trade, for a five-month project to assess the physical and mechanical properties of 3D printed concrete.

 

In the UK, the Company has supported funding applications for a number of newly proposed EPSRC (Engineering and Physical Sciences Research Council) Centres for Doctoral Training (CDT) and key UK research hubs relevant to Versarien's core business. Following the end of the Graphene Flagship Core 3 project, Versarien has submitted an EIC Transition grant application, together with other academic and industry partners. The Company is also involved in discussions regarding future European Commission proposals for one of the new candidate European Partnerships, 'Innovative Materials for EU', and has pledged support for new consortia such as 2D-MIC (2D Materials Industry & Innovation Consortium). The UK's re-entry into Horizon Europe from January 2024 will be crucial for our participation in such initiatives.

 

We are pleased with the increasing level of commercial engagement in both of the Company's core areas of leisure and construction. The Company's strategy, which is focused on a light manufacturing model, is progressing as planned and we look forward to updating shareholders on further progress in due course."

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
GMSPPGPWUUPWGRB
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.